+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Manufacturing Market by Service, End-User - Global Forecast 2025-2030- Product Image
Pharmaceutical Contract Manufacturing Market by Service, End-User - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Contract Manufacturing Market by Service, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968717
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Contract Manufacturing Market grew from USD 114.07 billion in 2023 to USD 123.64 billion in 2024. It is expected to continue growing at a CAGR of 8.46%, reaching USD 201.46 billion by 2030.

The pharmaceutical contract manufacturing market revolves around outsourcing manufacturing services of drugs to third-party firms, allowing pharmaceutical companies to focus on core operations such as research and development. This scope includes producing active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The necessity lies in cost reduction, access to state-of-the-art manufacturing facilities, and the agility they provide to pharmaceutical companies facing demand fluctuations. Key applications involve large-scale production, process development, and trial production amidst stringent regulations. In terms of end-use, biopharmaceutical companies, generic drug manufacturers, and even smaller biotech firms rely on contract manufacturing organizations (CMOs) for scaling operations.

The market's growth is fueled by increasing demand for generic drugs, technological advancements, and a surge in outsourcing by big pharma companies to CMOs. Emerging markets displaying significant pharmaceutical growth, coupled with heightened investments in biologics development, create opportunities. CMOs that expand capabilities in specialized dosage formulations, like injectables and controlled-release medicines, are well-positioned to capitalize on this. Digitalization and process automation stand as pivotal areas for innovation, enhancing efficiency and traceability within manufacturing processes.

Challenges include managing compliance with stringent regulatory requirements across various international markets, which can impede timely production and product approval. Intellectual property concerns and the risk of supply chain disruptions also pose significant obstacles. The market operates in a competitive landscape influenced by the availability of advanced manufacturing technologies and the need for strategic partnerships.

To seize opportunities, CMOs should focus on expanding their service portfolios by embracing cutting-edge technologies such as continuous manufacturing and investing in sustainable and green manufacturing approaches. Increased collaboration with biopharmaceutical companies for complex biologics production offers significant growth potential. Additionally, fostering agility in operations through robust automation and adopting scalable processes can help overcome some market limitations. Overall, the nature of the market is dynamic, driven by rapid technological advancements and evolving regulatory landscapes.

Understanding Market Dynamics in the Pharmaceutical Contract Manufacturing Market

The Pharmaceutical Contract Manufacturing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising Demand for Generics and Biological Therapies
    • Increasing Investments in Pharmaceutical R&D and Manufacturing
    • Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
  • Market Restraints
    • Introduction of Serialization Standards
  • Market Opportunities
    • Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector
    • Growing Demand for Cell and Gene Therapies for Targeted Treatment
  • Market Challenges
    • Changing Trade Policies Between Countries

Exploring Porter’s Five Forces for the Pharmaceutical Contract Manufacturing Market

Porter’s Five Forces framework further strengthens the insights of the Pharmaceutical Contract Manufacturing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pharmaceutical Contract Manufacturing Market

External macro-environmental factors deeply influence the performance of the Pharmaceutical Contract Manufacturing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pharmaceutical Contract Manufacturing Market

The Pharmaceutical Contract Manufacturing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pharmaceutical Contract Manufacturing Market

The Pharmaceutical Contract Manufacturing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Pharmaceutical Contract Manufacturing Market

The Pharmaceutical Contract Manufacturing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group GmbH, Almac Group, Amgen Inc., Baxter International Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., Curia Global, Inc., Danaher Corporation, Dr. Reddy’s Laboratories Ltd., Elkos Group, Evonik Industries AG, Famar Group, Fareva Group, Jubilant Pharma Limited, Kryptochem Medicament Pvt. Ltd., Lonza Group, Midas Pharma GmbH, Mitsubishi Tanabe Pharma Corporation, Nipro Group, Novartis AG, Pfizer Inc., Pidolma Healthcare, PYRAMID Laboratories, Inc., Recipharm AB, Serum Institute of India Ltd., Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Service
    • Biologics Manufacturing Services
      • Biologics API Manufacturing Services
      • Biologics FDF Manufacturing Services
    • Drug Development Services
    • Pharmaceutical Manufacturing Services
      • Pharmaceutical API Manufacturing
        • Capsule Manufacturing Services
        • Oral Liquid Manufacturing Services
        • Parenteral/Injectable Manufacturing Services
        • Tablet Manufacturing Services
      • Pharmaceutical FDF Manufacturing
    • Secondary Packaging Services
  • End-User
    • Big Pharma
    • Generic Pharmaceutical Companies
    • Small & Mid-Size Pharma
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Demand for Generics and Biological Therapies
5.1.1.2. Increasing Investments in Pharmaceutical R&D and Manufacturing
5.1.1.3. Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
5.1.2. Restraints
5.1.2.1. Introduction of Serialization Standards
5.1.3. Opportunities
5.1.3.1. Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector
5.1.3.2. Growing Demand for Cell and Gene Therapies for Targeted Treatment
5.1.4. Challenges
5.1.4.1. Changing Trade Policies Between Countries
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Pharmaceutical Contract Manufacturing Market, by Service
6.1. Introduction
6.2. Biologics Manufacturing Services
6.2.1. Biologics API Manufacturing Services
6.2.2. Biologics FDF Manufacturing Services
6.3. Drug Development Services
6.4. Pharmaceutical Manufacturing Services
6.4.1. Pharmaceutical API Manufacturing
6.4.1.1. Capsule Manufacturing Services
6.4.1.2. Oral Liquid Manufacturing Services
6.4.1.3. Parenteral/Injectable Manufacturing Services
6.4.1.4. Tablet Manufacturing Services
6.4.2. Pharmaceutical FDF Manufacturing
6.5. Secondary Packaging Services
7. Pharmaceutical Contract Manufacturing Market, by End-User
7.1. Introduction
7.2. Big Pharma
7.3. Generic Pharmaceutical Companies
7.4. Small & Mid-Size Pharma
8. Americas Pharmaceutical Contract Manufacturing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pharmaceutical Contract Manufacturing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Maiva Pharma secures USD 119 million investment to expand manufacturing with new Hosur facility
11.3.2. Kuhne Holding AG acquires Aenova Group from BC Partners
11.3.3. Tonix Pharmaceuticals partners with Almac for dual-source commercial production of Tonmya
11.3.4. Advent International merges Cohance Lifescience with Suven Pharma
11.3.5. Aurobindo Pharma partners with Merck Sharp and Dohme to enter biologics contract manufacturing market
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET DYNAMICS
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 44. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 45. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 46. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 47. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 71. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 72. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 73. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 74. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 76. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 77. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 78. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 79. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 89. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 119. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 135. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 140. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 145. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 150. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 155. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 162. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 163. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 164. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 165. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 180. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 182. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 183. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 184. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 185. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 187. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 188. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 189. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 190. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 210. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 225. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Pharmaceutical Contract Manufacturing market, which are profiled in this report, include:
  • AbbVie, Inc.
  • Aenova Group GmbH
  • Almac Group
  • Amgen Inc.
  • Baxter International Inc.
  • Biozoc Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Curia Global, Inc.
  • Danaher Corporation
  • Dr. Reddy’s Laboratories Ltd.
  • Elkos Group
  • Evonik Industries AG
  • Famar Group
  • Fareva Group
  • Jubilant Pharma Limited
  • Kryptochem Medicament Pvt. Ltd.
  • Lonza Group
  • Midas Pharma GmbH
  • Mitsubishi Tanabe Pharma Corporation
  • Nipro Group
  • Novartis AG
  • Pfizer Inc.
  • Pidolma Healthcare
  • PYRAMID Laboratories, Inc.
  • Recipharm AB
  • Serum Institute of India Ltd.
  • Siegfried Holding AG
  • Sycon Healthcare
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 123.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 201.46 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Pharmaceutical Contract Manufacturing & Research Services Market by Service, End-User - Global Forecast 2025-2030 - Product Image

Pharmaceutical Contract Manufacturing & Research Services Market by Service, End-User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030 - Product Image

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Fill-finish Pharmaceutical Contract Manufacturing Market by Product, End-users - Global Forecast 2025-2030 - Product Image

Fill-finish Pharmaceutical Contract Manufacturing Market by Product, End-users - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • 799 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule, Oral Liquid), Biologics (API, FDF), Packaging & Labelling, Fill-finish), End Users, Region - Global Forecast to 2029 - Product Image

Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule, Oral Liquid), Biologics (API, FDF), Packaging & Labelling, Fill-finish), End Users, Region - Global Forecast to 2029

  • Report
  • 385 Pages
  • Global
From

About the Pharmaceutical Contract Manufacturing Market

Pharmaceutical Contract Manufacturing (PCM) is a type of pharmaceutical manufacturing in which a company outsources the production of a drug or medical device to a third-party manufacturer. This type of manufacturing is often used when a company does not have the resources or expertise to produce a product in-house. PCM can also be used to reduce costs, increase production capacity, and improve product quality. PCM services can include formulation development, process optimization, analytical testing, packaging, and labeling. The contract manufacturer is responsible for ensuring that the product meets all regulatory requirements and is of the highest quality. Some of the major players in the PCM market include Patheon, Catalent, Recipharm, Aenova, and Vetter. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.